Joel Greenblatt Summit Therapeutics Inc. Transaction History
Gotham Asset Management, LLC
- $10.2 Billion
- Q4 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 15,785 shares of SMMT stock, worth $317,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,785
Previous 15,908
0.77%
Holding current value
$317,120
Previous $348,000
19.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$491 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$234 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$159 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$132 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$113 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.04B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...